BioSpace News Archive

Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and treated, has closed an oversubscribed $46.7 million Series B financing. The proceeds from the financing will support continu

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovix TM , a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. Unlike currently available serological COVID-19 tests that detect an antibody respons

Medial EarlySign (earlysign.com), a leader in AI-based clinical data solutions to aid in the early detection and prevention of high-burden diseases, and leading management consulting firm Centric Consulting today announced a partnership to enable US-based hospitals and healthcare organizations to utilize existing data in order to identify and prioritize patients for care.

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will showcase its latest X-ray tubes and sources, digital detectors, connect and control devices, and software solutions at the 32 nd annual European Congress of Radiology (ECR). The European Society of Radiology’s 2020 congress has transitioned to a virtual exhibition format, which will take place July 15 - 21, 2020. In addition to Varex’s existing X-

Dyadic International Announces Fully Funded Human Health R&D Collaboration with a Top Five Pharmaceutical Company today announced that it has entered into a new, fully-funded collaboration with another top five global pharmaceutical company.

Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods. Neogen’s new Soleris ® Next Generation (NG) can rapidly detect and enumerate a wide variety of microorganisms that can threaten the safe

RLDatix, the leading provider of intelligent patient safety solutions, today announced a new framework—Applied Safety Intelligence™—that will tighten the relationship between patient safety and risk management by moving the industry from a retrospective review of adverse events toward a future of proactive prevention.

The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests

The Solve ME/CFS Initiative (Solve M.E.) today announced the official launch of the You + M.E. Registry and Biobank, a resource of clinical information, patient-reported symptoms, and bio samples that can be used by researchers to better understand Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS) or ME/CFS.

APHA, NACo and Healthy Places by Design to collaborate on capacity-building efforts to accelerate community change